captopril has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, C; Gadad, BS; German, DC; Harris, SL; Li, W; Richardson, JR; Sonsalla, PK; Wong, LY | 1 |
1 other study(ies) available for captopril and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Captopril; Dopaminergic Neurons; Immunohistochemistry; Male; Mice; MPTP Poisoning; Nerve Degeneration; Neuroprotective Agents; Rats | 2013 |